PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 17, 2026Microorganisms1 citationsOpen Access

The Predatory Bacteria Bdellovibrio bacteriovorus LR3: A Potential Biocontrol Agent Against Gram-Negative Pathogenic Microorganisms

View Full Paper
АША. П. ШороховаВПВ. Н. ПоливцеваTATatiana N. Abashina

Key Points

  • The aim is to investigate Bdellovibrio bacteriovorus LR3 as a biocontrol agent against Gram-negative pathogens in mushroom cultivation.
  • Isolated Bdellovibrio bacteriovorus LR3 from water of the Lyubozhikha River.
  • Characterized predator-prey dynamics with Pseudomonas tolaasii.
  • Utilized electron microscopy for visualization.
  • Conducted 16S rRNA gene sequence analysis.
  • Determined optimal temperature and pH for effective interactions.
  • Bdellovibrio bacteriovorus LR3 effectively preys on Pseudomonas tolaasii.
  • Optimal conditions for predator-prey interactions were identified.
  • Demonstrated potential against clinical pathogens like Salmonella and Escherichia.
  • Suggests B. bacteriovorus LR3 can be a valuable tool in biocontrol strategies.

Abstract

The paper describes a predatory Gram-negative bacterium from the genus Bdellovibrio, which was isolated from water of the Lyubozhikha River. As revealed by electron microscopy, the bacterium is an intracellular predator of Gram-negative microorganisms. Its prey range includes Pseudomonas tolaasii, the phytopathogen responsible for brown spot disease in the cultivated button mushroom (Agaricus bisporus). Based on the results of a 16S rRNA gene sequence analysis, the bacterium was identified as Bdellovibrio bacteriovorus strain LR3. We characterized the predator–prey dynamics between B. bacteriovorus LR3 and P. tolaasii, determining the optimal temperature and pH conditions for this interaction. Our results demonstrate the potential of B. bacteriovorus LR3 as a biocontrol agent against P. tolaasii in mushroom cultivation. The possibility of using B. bacteriovorus LR3 against clinical cases Salmonella and Escherichia infections is also addressed.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Шорохова et al. (2026) studied this question.

synapsesocial.com/papers/696b2631d2a12237a93496d7https://doi.org/10.3390/microorganisms14010190
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure determination of tolaasin, an extracellular lipodepsipeptide produced by the mushroom pathogen, Pseudomonas tolaasii Paine1991 · 180 citations
  2. 2Prokka: rapid prokaryotic genome annotation2014 · 20,211 citations
  3. 3Genome sequence-based species delimitation with confidence intervals and improved distance functions2013 · 6,834 citations
  4. 4Bdellovibrio bacteriovorus gen. et sp. n., a predatory, ectoparasitic, and bacteriolytic microorganism1963 · 460 citations
  5. 5Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications2018 · 1,832 citations